Lyle joined AIT/Axis in 2013 and leads the business development team. Lyle develops strategies to meet the needs of the varied markets that Axis serves.
Lyle has worked in various leadership roles in the healthcare industry including hospital, payer and vendor sectors. These roles included leading clinical divisions, business development, marketing, sales and strategic planning. He has also conducted several sales training courses for technology and medical companies.
Lyle earned his undergraduate degree in Marketing from Indiana University and his Master of Science in Healthcare Administration & Planning from the University of Cincinnati. He completed his one year residency at Columbus Regional Hospital in Columbus, IN.
Dr. Behonick joined AIT/Axis in 2009 and serves as Lab Director and Chief Toxicologist. Prior to coming to AIT, he directed a laboratory serving the Office of the Chief Medical Examiner for the Commonwealth of Massachusetts (more than 4,000 cases/year) and was an Assistant Professor of Pathology at the University of Massachusetts Medical School in Worcester, Massachusetts. Prior to that role, Dr. Behonick completed six years of service as a Forensic Toxicologist with the Virginia Department of Forensic Science Western Laboratory in Roanoke, Virginia. Dr. Behonick has extensive experience in complex postmortem drug-related cases, notably involving the opiate and opioid classes, with extensive scientific expert witness testimony experience in driving under the influence (DUI/DUID) of alcohol and/or drug(s) criminal court cases.
His educational background includes a Bachelor of Science from The Citadel in Charleston, South Carolina, a Master of Science from Hahnemann University in Philadelphia, Pennsylvania, and a Ph.D. from St. John’s University in Queens, New York. In 1998 Dr. Behonick completed a postdoctoral Research Associateship through the National Research Council/National Academy of Sciences at the United States Army Medical Research Institute of Chemical Defense, Aberdeen-Edgewood Area, Maryland. He was awarded board certification as a Fellow American Board of Forensic Toxicology ( F-ABFT) in November 2004 and most recently qualified for re-certification in July 2014.
Kevin has been with AIT Laboratories/Axis Forensic Toxicology for more than 13 years. He has extensive experience in research and development as well as laboratory management. His areas of expertise include liquid chromatography mass spectrometry (LC/MS) and the analytical detection and toxicology of new psychoactive substances (NPS) such as substituted cathinones, synthetic cannabinoids, NBOME hallucinogens, fentanyl analogs, and opioid research chemicals. Kevin oversees all method development and validation of analytical methods for NPS at Axis. He has provided fact and expert witness testimony in drug chemistry, human performance toxicology, and postmortem toxicology matters in numerous states.
His educational background includes a Bachelor of Arts in Biology from Franklin College in Franklin, Indiana, and a Master of Science in Forensic Toxicology form the University of Florida’s Veterinary School of Medicine. He is certified as a Diplomate of the American Board of Forensic Toxicology in forensic toxicology (D-ABFT-FT) and holds regular membership with the American Academy of Clinical Toxicology (AACT) and the Society of Forensic Toxicologists (SOFT). Kevin has published papers in peer-reviewed scientific journals such as the Journal of Analytical Toxicology (JAT) and Forensic Science International (FSI) and presented research at national meetings such as the SOFT annual conference and the American Association of Clinical Chemistry (AACC).